Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser(2)]exendin(1-9) (HSEGTFTSD; homologous to a conserved domain in the glucagon/GLP-1 family) enhance associative and spatial learning through GLP-1R. [Ser(2)]exendin(1-9), but not GLP-1, is also active when administered peripherally. GLP-1R-deficient mice have a phenotype characterized by a learning deficit that is restored after hippocampal Glp1r gene transfer. In addition, rats overexpressing GLP-1R in the hippocampus show improved learning and memory. GLP-1R-deficient mice also have enhanced seizure severity and neuronal injury after kainate administration, with an intermediate phenotype in heterozygotes and phenotypic correction after Glp1r gene transfer in hippocampal somatic cells. Systemic administration of [Ser(2)]exendin(1-9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons. Brain GLP-1R represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1 is involved in cognitive brain function and learning, 98”
From GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits (2026) · cites this paper as [98]
In the citing paper
“GLP1-RAs is known for its neuroprotective action, and more recent results have emerged, showing a potential benefit in people with AD [85,86,87].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [86]
In the citing paper
“They are involved in multiple biological pathways that could be beneficial in AD including improvement of BBB integrity and vascular health, promotion of homeostasis in microglia and astrocytes, positive effects on adaptative immune cells (including natural killer cells and activated regulatory T cells), improvement of synaptic viability, and neuroprotection [17–26].”
In the citing paper
“Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23–26, 46–48];”
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,171
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 1×
“Indeed, GLP-1 exerts effects on glucose-dependent insulin secretion, insulin biosynthesis, gastrointestinal motility, islet b-cell neogenesis, energy homeostasis and food intak”
BackgroundSniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“Immunohistochemical comparison of the CA3 subregion of the hippocampus using Fluorojade-B, a fluorochrome stain specific for degenerating neuron”
MethodKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationEnvironmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citation
Cited by
Items 801–859 of 859
The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
Hsieh, J. (2012) · TSpace (University of Toronto)
Callisaya, M. L., & Moran, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00012-3
Sweet Memories: Hippocampal Regulation of Energy Intake
Hannapel, R. (2018) · Digital Archive @ GSU · doi:10.57709/13428396
Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2019.4
Self-citationGut-brain axis: Central impact of gut peptides and metabolic drug on monoamine neurotransmission
Omoloye, A. (2019) · DMU Open Research Archive (De Montfort University)
Zhang, Q., Zhang, X., & Niu, C.-Y. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i11.393
Dysfunction of a Peripheral Lipid Sensor Gpr120 Causes Pgd2-microglia-provoked NeuroinflammationPreprint
Iwasa, K., Yamamoto, S., Yamashina, K., Sakemoto, C., Yagishita-Kyo, N., Maruyama, K., Awaji, T., Takei, Y., Hirasawa, A., & Yoshikawa, K. (2020) · Research Square · doi:10.21203/rs.3.rs-114598/v1
Qi, L., Lin, L., Zheng, J., Liu, X., Liu, X., Chen, Z., & Liu, L. (2021) · Research Square · doi:10.21203/rs.3.rs-845788/v1
Glucagon receptor family in GtoPdb v.2021.3
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2021.3 · Cited by 1
Self-citationNeuroprotective effects of lipid emulsion on brain injury in rats
단위오까모토마사 (2021) · YUHSpace (Yonsei University Medical Library)
Li, X., Gu, J., Wang, Z., Lin, J., Zhao, T., Wang, R.-S., Duan, T., Li, Z., Dong, R., Wang, W., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1127751/v1
Perspectives on Neuroscience and Behavior
(2004) · The Neuroscientist · doi:10.1177/1073858404101002
Li, J., Liang, X., Alam, M. S., Luo, H., Zhang, Y., Peng, B., Xiao, Q., Zhang, Z., Liu, L., & He, S. (2020) · doi:10.21203/rs.3.rs-17136/v1
TEKİN, Ö., Uyanıkgil, Y., & Taşkıran, D. (2022) · Ege Tıp Dergisi · doi:10.19161/etd.1180666
Plant bioactives in balancing glucose homeostasis during aging and related diseases
Mandal, S., Davargaon, R. S., & Devi, S. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90581-7.00015-3
Andraini, T., Mardatillah, J., Kartinah, N. T., Paramita, N., Santoso, . I. S., Yolanda, S., Puspasari, B. C., & Rusli, H. (2022) · Comparative Exercise Physiology · doi:10.3920/cep220020
New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system
Łupina, M., & Listos, J. (2023) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2023-0040
GLP1R Agonists Activate Human POMC NeuronsPreprint
Mazzaferro, S., Chen, H. C., Cahn, O., Yang, A., Shepilov, D., Chen, J., Alcaino, C., Macarelli, V., Mali, I. D., Gribble, F. M., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4855485
Role of Nutrition in Maintaining Brain Health
Dehghani-Beshneh, M., Khatami, M., Ghiasinejad, S., & Sarasyabi, M. S. (2024) · Nutritional neurosciences · doi:10.1007/978-981-97-4117-5_6 · Cited by 1
Peptides, Proteins and Antibodies
Gennaro, S. I. D., & Lalatsa, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_19
Neuroprotective Effect of Sitagliptin beyond the Incretin Effect: A Narrative Review
Pourbagher‐Shahri, A. M., & Forouzanfar, F. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273367858250321124131
Lee, Y.-S., Seo, Y.-L., Song, G. J., Cho, K. S., Yoo, Y. K., & Cheong, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6546219/v1 · Cited by 1
Les analogues de GLP-1 dans l’arthrose : avancées et perspectives
Berenbaum, F. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.06.003
Effects of semaglutide on mental health
Rozhdestvenskaya, V. A., Iuzbashian, P. G., Romanov, D. V., Shchurenkov, A. V., Kazaryan, P. A., Sheyanov, A. M., Zubacheva, E. O., & Fedyainova, I. K. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512509128 · Cited by 1
Epidemiology related to confluence of diabetes and Alzheimer
Yadav, P., & Singh, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00004-0
Glucagon-like Peptides and Insulin Sensitivity
Holst, J. J., & Knop, F. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_13
Research Progress of GLP-1 Receptor Agonists in the Treatment of Alzheimer’s Disease
勾, 琳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123625
Role of GLP-1 receptors in the effect of hypericin on mouse neuroblastoma cell line (NB2a)
Öztekin, F., Darıverenli, E., Ölmez, E., & Gidener, S. (2025) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1786639
Luo, Y., Chen, T., Li, M., Kubera, M., Zhang, Y., Huang, Y., & Maes, M. H. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.703942
Liu, S., Chen, Q., Liu, H., Chen, Z., Ding, N., Sun, T., & Wang, L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.033
Insulin and Incretin Receptor Agonists Reciprocally Alter Their Blood–Brain Barrier Permeabilities
Fry, A., Rose, A., Weaver, R. R., Hansen, K., Blevins, J. E., Banks, W. A., & Rhea, E. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104611 · Cited by 1
Self-citationAlhowail, A. H., Mouslem, A. K. A., Almatrafi, M. A., & Aldubayan, M. A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1851072 · Cited by 3
GLP-1 receptor agonists in addiction and affective disorders: Implications for dual disorders
Seijas‐Amigo, J., Salgado‐Barreira, Á., Eiras, S., Arias-Rivas, S., Rodríguez-Carnero, G., & González‐Juanatey, J. R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111802 · Cited by 3
Incretins: From Gene Expression to Secretion and Action of GLP-1 and GIP
Lobato, C. B., & Holst, J. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00004-4
Mills, A. M., & Noble, E. E. (2026) · Appetite · doi:10.1016/j.appet.2026.108729
Yu, T., Mai, Q., Wang, Q., Pan, M., Xiong, Y., Kuang, L., & Liu, H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1894856
Brain-Wide Connectivity of GLP1R Neurons in the Thalamic Reticular Nucleus
Zhang, X., Zhu, S., Lan, J., Duan, S., Han, Y., & Shi, P. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin52117
Schifano, F., Luca, M. A. D., Bonaccorso, S., Arillotta, D., Floresta, G., Martinotti, G., Papanti, G. D., Corkery, J., Chiappini, S., & Guirguis, A. (2026) · Current Psychiatry Reports · doi:10.1007/s11920-026-01709-w · Cited by 1
Diniz, C. G., Bento-Torres, N. V. O., da Costa, E. R., Magalhães, N. G. D. M., de Melo, M. A. D., Pereira, P. D. C., Carvalho, J. P. R., Magno, G. M., Bento‐Torres, J., Sosthenes, M. C. K., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106922
Zhang, L., Liu, X., Si, C., Hou, X., Hu, X., Chen, Y., Hu, J., Turck, C. W., Shan, B., & Zhang, Y. (2026) · Science Advances · doi:10.1126/sciadv.aeh4670
Adhikari, S., Carlyle, B. C., & de Wet, H. (2026) · The Journal of Precision Medicine Health and Disease · doi:10.1016/j.premed.2026.100057
Горгуль, Ю. А., & Zaitsev, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188036
Schechter, M., Sehtman-Shachar, D. R., Fishkin, A., Mosenzon, O., Cukierman‐Yaffe, T., Sharon, R., Leibowitz, G., Arkadir, D., & Aharon‐Hananel, G. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70315 · Cited by 1
BindingDB Entry 50038326: Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors.
BindingDB (2012) · UC San Diego · doi:10.7270/q2hd7wj0
BindingDB Entry 50038438: Small-molecule agonists for the glucagon-like peptide 1 receptor.
BindingDB (2012) · UC San Diego · doi:10.7270/q21r6rd8
BindingDB (2019) · UC San Diego · doi:10.7270/q2ng4svk
BindingDB Entry 50030464: Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors.
BindingDB (2010) · UC San Diego · doi:10.7270/q2513z7c
BindingDB (2016) · UC San Diego · doi:10.7270/q2nv9kvs
BindingDB Entry 50015246: Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
BindingDB (2009) · UC San Diego · doi:10.7270/q2qr4wm2
Dewer, M. A., Dawod, S. G., Elbadawy, N. M., & Bassiouny, E. A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00345-7
Genetic Manipulation of Learning and Memory
Dunning, J. (2006) · Elsevier eBooks · doi:10.1016/b978-012397632-1/50014-9
Metadata
- Authors
- During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., & Haile, C. N.
- Affiliations
- University of Auckland (NZ)
- Thomas Jefferson University (US)
- St. Louis VA Medical Center (US)
- University of Toronto (CA)
- Corresponding author
- During, Matthew J
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-08-17
- Volume
- 9
- Issue
- 9
- Pages
- 1173-1179
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2124852816
- Cited by
- 851
- References
- 42
- Citations by year
- 2026: 34 · 2025: 40 · 2024: 50 · 2023: 39 · 2022: 58 · 2021: 53 · 2020: 44 · 2019: 36 · 2018: 37 · 2017: 39 · 2016: 34 · 2015: 54 · 2014: 46 · 2013: 47 · 2012: 43
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Marsden Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- GLP-1 receptor, glucagon-like peptide-1, associative learning, spatial learning, memory, hippocampus, neuroprotection, kainate-induced seizures, neuronal apoptosis, cognitive enhancement, gut-brain signaling
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Administration, Intranasal, Amino Acid Sequence, Animals, Behavior, Animal, Cognition, Glucagon, Hippocampus, Kainic Acid, Learning, Male, Molecular Sequence Data, Neurons, Peptide Fragments, Protein Precursors, Seizures, Signal Transduction, Gene Expression, Rats, Sprague-Dawley, Apoptosis, Sequence Homology, Amino Acid, Gene Transfer Techniques, Receptors, Glucagon, Mice, Knockout, Neuroprotective Agents, Mice, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.